AAAAAA

   
Results: 1-17 |
Results: 17
Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds
Authors: Venkatachalam, TK Sudbeck, EA Mao, C Uckun, FM
Citation: Tk. Venkatachalam et al., Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds, BIOORG MED, 11(4), 2001, pp. 523-528
Regiospecific synthesis, X-ray crystal structure and biological activitiesof 5-bromothiophenethyl thioureas
Authors: Venkatachalam, TK Sudbeck, EA Uckun, FM
Citation: Tk. Venkatachalam et al., Regiospecific synthesis, X-ray crystal structure and biological activitiesof 5-bromothiophenethyl thioureas, TETRAHEDR L, 42(38), 2001, pp. 6629-6632
Tyrosine kinase inhibitors against EGF receptor-positive malignancies
Authors: Sudbeck, EA Ghosh, S Liu, XP Zheng, YG Myers, DE Uckun, FM
Citation: Ea. Sudbeck et al., Tyrosine kinase inhibitors against EGF receptor-positive malignancies, METH MOL B, 166, 2001, pp. 193-218
Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a majordeterminant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase
Authors: Venkatachalam, TK Sudbeck, EA Mao, C Uckun, FM
Citation: Tk. Venkatachalam et al., Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a majordeterminant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase, BIOORG MED, 10(18), 2000, pp. 2071-2074
Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity
Authors: Dong, YH Venkatachalam, TK Narla, RK Trieu, VN Sudbeck, EA Uckun, FM
Citation: Yh. Dong et al., Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity, BIOORG MED, 10(1), 2000, pp. 87-90
Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity
Authors: Venkatachalam, TK Sudbeck, EA Mao, C Uckun, FM
Citation: Tk. Venkatachalam et al., Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity, ANTIVIR CHE, 11(5), 2000, pp. 329-336
An inhibitor of Janus kinase 3: 4-(4-hydroxyphenylamino)-6,7-di-methoxyquinazolin-1-ium chloride methanol solvate
Authors: Sudbeck, EA Jennissen, JD Liu, XP Uckun, FM
Citation: Ea. Sudbeck et al., An inhibitor of Janus kinase 3: 4-(4-hydroxyphenylamino)-6,7-di-methoxyquinazolin-1-ium chloride methanol solvate, ACT CRYST C, 56, 2000, pp. 1282-1283
Structure-based drug design of non-nucleoside inhibitors for wild-type anddrug-resistant: HIV reverse transcriptase
Authors: Mao, C Sudbeck, EA Venkatachalam, TK Uckun, FM
Citation: C. Mao et al., Structure-based drug design of non-nucleoside inhibitors for wild-type anddrug-resistant: HIV reverse transcriptase, BIOCH PHARM, 60(9), 2000, pp. 1251-1265
Structure-based design of specific inhibitors of janus kinase 3 as apoptosis-inducing antileukemic agents
Authors: Sudbeck, EA Liu, XP Narla, RK Mahajan, S Ghosh, S Mao, C Uckun, FM
Citation: Ea. Sudbeck et al., Structure-based design of specific inhibitors of janus kinase 3 as apoptosis-inducing antileukemic agents, CLIN CANC R, 5(6), 1999, pp. 1569-1582
Specificity of alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase
Authors: Ghosh, S Zheng, YG Jun, X Mahajan, S Mao, C Sudbeck, EA Uckun, FM
Citation: S. Ghosh et al., Specificity of alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase, CLIN CANC R, 5(12), 1999, pp. 4264-4272
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N '-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistanthuman immunodeficiency virus
Authors: Mao, C Sudbeck, EA Venkatachalam, TK Uckun, FM
Citation: C. Mao et al., Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N '-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistanthuman immunodeficiency virus, BIOORG MED, 9(11), 1999, pp. 1593-1598
Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus
Authors: Mao, C Sudbeck, EA Venkatachalam, TK Uckun, FM
Citation: C. Mao et al., Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus, ANTIVIR CHE, 10(5), 1999, pp. 233-240
Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents
Authors: Ghosh, S Narla, RK Zheng, YG Liu, XP Jun, X Mao, C Sudbeck, EA Uckun, FM
Citation: S. Ghosh et al., Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents, ANTI-CAN DR, 14(5), 1999, pp. 403-410
Inhibitor of HIV-1 reverse transcriptase: N '-(5-bromo-2-pyridyl)-N-[2-(2,5-di-methoxyphenyl)ethyl] thiourea
Authors: Sudbeck, EA Jennissen, JD Venkatachalam, TK Ucukun, FM
Citation: Ea. Sudbeck et al., Inhibitor of HIV-1 reverse transcriptase: N '-(5-bromo-2-pyridyl)-N-[2-(2,5-di-methoxyphenyl)ethyl] thiourea, ACT CRYST C, 55, 1999, pp. 2122-2124
Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent
Authors: Atigadda, VR Brouillette, WJ Duarte, F Ali, SM Babu, YS Bantia, S Chand, P Chu, N Montgomery, JA Walsh, DA Sudbeck, EA Finley, J Luo, M Air, GM Laver, GW
Citation: Vr. Atigadda et al., Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent, J MED CHEM, 42(13), 1999, pp. 2332-2343
Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide]
Authors: Mahajan, S Ghosh, S Sudbeck, EA Zheng, YG Downs, S Hupke, M Uckun, FM
Citation: S. Mahajan et al., Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide], J BIOL CHEM, 274(14), 1999, pp. 9587-9599
Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase
Authors: Sudbeck, EA Mao, C Vig, R Venkatachalam, TK Tuel-Ahlgren, L Uckun, FM
Citation: Ea. Sudbeck et al., Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase, ANTIM AG CH, 42(12), 1998, pp. 3225-3233
Risultati: 1-17 |